Cholesterol-drug rejection rips new gash in Merck (Reuters)

[riky]

Cholesterol-drug rejection rips new gash in Merck
    (Reuters)

 

<p>You are not allowed to view links. Register or LoginReuters - Confidence in Merck & Co's  
earnings prospects withered on Tuesday, along with its stock
price, after U.S. regulators surprisingly rejected the
drugmaker's treatment to raise levels of "good" HDL
cholesterol.</p><br clear="all"/>


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080429/bs_nm/merck_dc